| (USD) | Mar 2026 | Y/Y change |
|---|---|---|
| Revenue | 0.00 | — |
| Operating expense | — | — |
| Net income | -12.51M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, SKYE returned -36.5% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | +178.8% |
| 1 year | -36.5% |
| 5 years | -99.3% |
| 10 years | -99.8% |
| All-time high | $20,000.00 (Nov 2014) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in SKYE would be worth today ›No. Skye Bioscience, Inc. has not paid a dividend in the past 12 months.
Skye Bioscience, Inc. stock trades on NASDAQ under the ticker symbol SKYE.
Skye Bioscience, Inc. is part of the Healthcare sector.
Skye Bioscience, Inc. has a market cap of 9.25M USD, based on the latest quote.
Skye Bioscience, Inc. is expected to report earnings around Nov 9, 2026. That date is an estimate and has not been confirmed by the company.
